Crabb SJ, Griffiths G, Dunkley D, Downs N, et al. Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial. Eur Urol 2022 Jun 7. pii: S0302-2838(22)02393.
PMID: 35688662